Dr. Ming Lim is an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah since October 2018. She earned her medical degree at Cambridge University, England, and completed her 2-year Foundation Training in the United Kingdom. She then completed a residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at the University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors. She is the recipient of 2 foundation-sponsored grants to determine the epidemiology and risk factors for inhibitor development in non-severe hemophilia A patients. She has co-authored over 40 peer-reviewed publications.
Dr. Lim is the Medical Director for the Benign Hematology Program at the University of Utah Health, and also the Medical Director for the Utah Center for Bleeding & Clotting Disorders at the University of Utah Health. Nationally, she serves on the American Board of Internal Medicine Hematology Item-Writing Task Force and is a member of the American Society of Hematology Subcommittee on Stewardship and Systems-Based Hematology.